Group 1 - Morgan Stanley lowered the price target on Aramark (ARMK) to $43 from $44 [1] - The firm maintains an Equal Weight rating on Aramark shares [1] - Aramark's organic growth of 13.8% missed estimates by approximately 200 basis points [1] Group 2 - The 2026 guidance provided by Aramark was roughly in line with expectations [1]

Core Insights - Aramark (NYSE:ARMK) is projected to have a positive future with a price target of $44, indicating a potential increase of 22.09% from its current price of $36.04 [1][6] Financial Performance - The company reported quarterly earnings of $0.64 per share, slightly below the Zacks Consensus Estimate of $0.65, resulting in a negative surprise of 1.54% [2][6] - Revenue for the quarter ending September 2025 was $5.05 billion, missing the Zacks Consensus Estimate by 2.11%, but showing an increase from $4.42 billion in the same quarter the previous year [3][6] Stock Performance - Aramark's stock is currently priced at $36.04, reflecting a decrease of approximately 5.23% with a trading range between $35.07 and $37.47 during the day [4] - Over the past year, the stock has fluctuated between a high of $44.49 and a low of $29.92, indicating market volatility [4] Market Position - With a market capitalization of approximately $9.47 billion, Aramark is a significant player in the business services sector [5] - The stock's trading volume on the NYSE was 9,143,082 shares, highlighting its prominence in the market [5]

Core Insights - Aramark reported an earnings per share (EPS) of $0.33, which was significantly below the estimated $0.65, indicating inconsistency in meeting market expectations [2][6] - The company's revenue for the quarter was approximately $5.05 billion, exceeding the estimated $4.92 billion but falling short of the Zacks Consensus Estimate of $5.16 billion, reflecting a 14.3% year-over-year increase [3][6] - Following the earnings report, Aramark shares fell approximately 6%, reflecting investor disappointment and a cautious outlook for fiscal year 2026 with projected adjusted EPS between $2.18 and $2.28 [4][6] Financial Performance - Over the past four quarters, Aramark has exceeded consensus EPS estimates twice, showcasing some inconsistency in financial performance [2] - The company has consistently failed to surpass consensus revenue estimates over the last four quarters, despite showing revenue growth [3] - Financial metrics include a price-to-earnings (P/E) ratio of 29.37, a price-to-sales ratio of 0.52, and an enterprise value to sales ratio of 0.50, indicating a stable financial position [5] Market Context - The U.S. stock market experienced a downturn, with the Dow Jones index dropping over 150 points, contributing to the decline in Aramark's share price [4] - Competitors in the industry include Compass Group and Sodexo, which also provide similar services globally, highlighting the competitive landscape [1]

Market Overview - U.S. stocks traded lower, with the Dow Jones index falling more than 150 points, down 0.38% to 46,966.91, NASDAQ down 0.42% to 22,805.30, and S&P 500 down 0.40% to 6,707.46 [1] - European shares also declined, with the eurozone's STOXX 600 down 0.4%, Spain's IBEX 35 down 0.9%, London's FTSE 100 down 0.2%, Germany's DAX 40 down 0.6%, and France's CAC 40 down 0.4% [5] - Asian markets closed mostly lower, with Japan's Nikkei 225 down 0.10%, Hong Kong's Hang Seng down 0.71%, and China's Shanghai Composite down 0.46% [6] Company Earnings - Aramark (NYSE:ARMK) shares fell around 6% after reporting fourth-quarter earnings of 57 cents per share, missing the analyst consensus estimate of 65 cents per share, and quarterly sales of $5.048 billion, below the consensus estimate of $5.164 billion [2] Sector Performance - Communication services shares rose by 2.1% on Monday, while information technology stocks fell by 1.1% [1] Commodity Prices - Oil traded up 0.3% to $60.29, while gold traded down 0.3% at $4,083.20, silver up 0.1% to $50.700, and copper down 0.8% to $5.0235 [4] Notable Stock Movements - Kaixin Holdings (NASDAQ:KXIN) shares surged 104% to $0.6274, Autonomix Medical, Inc. (NASDAQ:AMIX) up 60% to $1.1602, and PACS Group, Inc. (NYSE:PACS) up 50% to $15.80 [8] - OneConstruction Group Limited (NASDAQ:ONEG) shares dropped 57% to $2.20, Taitron Components Incorporated (NASDAQ:TAIT) down 46% to $1.14, and Republic Power Group Limited (NASDAQ:RPGL) down 36% to $0.5399 [8] Economic Indicators - The NY Empire State Manufacturing Index rose to 18.70 points in November, compared to a reading of 10.70 points in October [9]

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

For the quarter ended September 2025, Aramark (ARMK) reported revenue of $5.05 billion, up 14.3% over the same period last year. EPS came in at $0.64, compared to $0.54 in the year-ago quarter.The reported revenue represents a surprise of -2.11% over the Zacks Consensus Estimate of $5.16 billion. With the consensus EPS estimate being $0.65, the EPS surprise was -1.54%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...

Core Viewpoint - The article discusses the expertise of a senior analyst and private portfolio manager with over 10 years of experience in generating value ideas in European and North American markets [1]. Group 1: Analyst Background - The analyst is a contributing author and analyst for the investing group iREIT®+HOYA Capital and Wide Moat Research LLC, covering various European markets including Scandinavia, Germany, France, UK, Italy, Spain, Portugal, and Eastern Europe [1]. - The focus is on identifying reasonably valued stock ideas within these markets [1]. Group 2: Investment Position - The analyst holds a beneficial long position in the shares of SDXAY through stock ownership, options, or other derivatives [1].

Core Insights - The article discusses the expertise of a senior analyst and private portfolio manager with over 10 years of experience in generating value ideas in European and North American markets [1] Group 1: Analyst Background - The analyst is a contributing author and analyst for the investing group iREIT®+HOYA Capital and Wide Moat Research LLC, covering various European markets including Scandinavia, Germany, France, UK, Italy, Spain, Portugal, and Eastern Europe [1] Group 2: Investment Focus - The analyst focuses on identifying reasonably valued stock ideas within the mentioned markets, indicating a strategic approach to investment opportunities [1]

Financial Data and Key Metrics Changes - For fiscal 2025, the company reported revenue of $18.5 billion, a 6% increase compared to the prior year, with organic revenue growth of 7% [16][20] - Adjusted operating income for the fourth quarter was $289 million, growing 6% on a constant currency basis, while full-year adjusted operating income was $981 million, up 12% [17][18] - The adjusted EPS for the fourth quarter was $0.57, a 6% increase, and for the full year, it was $1.82, reflecting almost a 20% increase [20][21] - The consolidated leverage ratio improved to 3.25 times, the lowest level in nearly 20 years, down from 3.4 times a year ago [21][22] Business Line Data and Key Metrics Changes - The U.S. segment reported organic revenue growth of 14% in the fourth quarter, driven by new business and base business growth [8][16] - The international segment also experienced consistent double-digit organic revenue growth of 14% in the fourth quarter, with strong contributions from various geographic regions [12][19] - The healthcare segment reported its best performance in over two years, with significant new business wins contributing to growth [9][11] Market Data and Key Metrics Changes - The company achieved an industry-leading client retention rate of 96.3%, contributing to a net new business growth of 5.6% [6][7] - The collegiate sports business experienced double-digit revenue growth, with per capita rates up 14% year over year [9][10] - The supply chain GPO network added over $1 billion in new purchasing spend for the second consecutive year, indicating strong market demand [7][13] Company Strategy and Development Direction - The company is focused on delivering exceptional hospitality services and is committed to creating significant value for shareholders [25][24] - There is a strong emphasis on leveraging technology and operational efficiencies to drive profitability and growth [14][19] - The company plans to maintain a growth agenda focused on culture, team capabilities, and process improvements [13][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to achieve net new business growth of 4-5% of prior year revenue, with retention levels exceeding 95% in fiscal 2026 and beyond [7][23] - The company anticipates organic revenue for fiscal 2026 to be between $19.45 billion and $19.85 billion, representing growth of 7%-9% [22][23] - Management acknowledged the impact of inflation, estimating it around 3% heading into the new fiscal year, while emphasizing effective management of the macro environment [14][21] Other Important Information - The company is expanding its enterprise-wide capabilities and has secured significant contracts, including a multi-year agreement with the University of Pennsylvania Health System [10][11] - The company is actively pursuing new opportunities in various sectors, including healthcare and corrections, indicating a robust pipeline for future growth [51][66] Q&A Session Summary Question: Can you delve into the shift in timing for new account openings? - Management indicated that the shift occurred across multiple businesses, including corrections and healthcare, and was client-driven rather than company-driven [30][31] Question: What is the implication of the Penn Medicine deal for future hospital groups? - Management believes there are significant new opportunities for self-op conversion in healthcare, with the Penn deal serving as a model for other institutions [51][52] Question: Can you discuss the organic revenue drivers for fiscal 2025 and 2026? - For fiscal 2025, base business growth was approximately 3.5%, with net new contributions around 1.5%, while for fiscal 2026, expected base business growth is 3-4% [56][57] Question: What are the factors behind the restructuring in the international business? - The restructuring is aimed at streamlining SG&A and optimizing operations, particularly in Europe and South America, despite the segment's healthy growth [75][76] Question: How does the company view retention rates moving forward? - Management aims to maintain a retention rate above 95%, with aspirations to achieve even higher levels, reflecting a commitment to continuous improvement [100][101]